BSN repricing to draw on US heat

EQT-owned German bandage maker BSN Medical (B/B2) is looking to reprice its €740m term loan ‘B’ at tighter terms just three months after signing, with leveraged finance bankers confident that the strength of the US loan market would make the adjustment possible.

  • 02 Oct 2012

BSN is looking to reduce the margin on the €455m euro-denominated tranche from 500bp to 425bp, and cut the margin on its €225m-equivalent US dollar tranche from 475bp to 325bp. The euro loans are offered at 99.5, with the dollar loans at par.

The Libor floors will remain at ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access:

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 BNP Paribas 10,542 20 17.55
2 Bank of America Merrill Lynch (BAML) 6,103 21 10.16
3 Citi 5,130 13 8.54
4 JP Morgan 4,681 6 7.79
5 Morgan Stanley 4,137 11 6.89

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 81,261.11 236 11.54%
2 Bank of America Merrill Lynch 66,433.81 187 9.43%
3 Wells Fargo Securities 57,637.40 170 8.18%
4 JPMorgan 53,570.42 158 7.61%
5 Credit Suisse 45,349.30 117 6.44%